HARVARD MANAGEMENT CO INC - Q2 2023 holdings

$1.02 Million is the total value of HARVARD MANAGEMENT CO INC's 33 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 31.2% .

 Value Shares↓ Weighting
FB  Meta Platforms Inccl a$325,985
-99.9%
1,135,9160.0%31.99%
+26.5%
GOOGL  Alphabet Inccap stk cl a$288,661
-99.9%
2,411,5400.0%28.33%
+7.8%
SGMS  Light & Wonder Inc$184,179
-99.9%
2,678,5710.0%18.08%
+7.0%
 Grab Holdings Limitedclass a ord$44,715
-99.9%
13,036,4820.0%4.39%
+6.5%
PCTTW BuyPurecycle Technologies Inc*w exp 03/17/202$26,705
-98.8%
2,498,170
+249.7%
2.62%
+1039.6%
NVDA SellNvidia Corporation$21,273
-99.9%
50,289
-24.2%
2.09%
+7.8%
TSM BuyTaiwan Semiconductor Mfg Ltdsponsored ads$20,421
-99.8%
202,347
+88.6%
2.00%
+91.0%
ASML BuyASML Holding N V$19,944
-99.9%
27,519
+36.3%
1.96%
+35.5%
AMD BuyAdvanced Micro Devices Inc$19,069
-99.8%
167,406
+49.3%
1.87%
+62.1%
TXG  10X Genomics Inc$10,394
-99.9%
186,1430.0%1.02%
-6.5%
 EQRX Inc$7,167
-99.9%
3,853,3670.0%0.70%
-10.4%
RXRX SellRecursion Pharmaceuticals Incl a$6,590
-99.9%
882,129
-41.6%
0.65%
-38.8%
 Rocket Lab Usa Inc$6,000
-99.9%
1,000,0000.0%0.59%
+38.9%
CFLT  Confluent Inc$4,604
-99.9%
130,3830.0%0.45%
+37.0%
 Tenaya Therapeutics Inc$3,952
-99.8%
673,2700.0%0.39%
+92.1%
NRIX  Nurix Therapeutics Inc$3,144
-99.9%
314,7620.0%0.31%
+5.1%
PCT SellPurecycle Technologies Inc$3,136
-100.0%
714,285
-71.4%
0.31%
-83.2%
PACB BuyPacific Biosciences Calif Inc$3,101
-99.9%
233,186
+1.8%
0.30%
+9.0%
GBIO  Generation Bio Co$2,807
-99.9%
510,3540.0%0.28%
+19.0%
SANA  Sana Biotechnology Inc$2,794
-99.8%
468,7490.0%0.27%
+70.2%
 Vigil Neuroscience Inc$2,721
-99.9%
289,4600.0%0.27%
-10.4%
 Tango Therapeutics Inc$2,352
-99.9%
708,3850.0%0.23%
-21.4%
KNTE SellKinnate Biopharma Inc$1,401
-100.0%
462,418
-7.1%
0.14%
-57.8%
DBTX SellDecibel Therapeutics Inc$1,255
-99.9%
326,029
-0.8%
0.12%
+18.3%
FULC SellFulcrum Therapeutics Inc$1,129
-99.9%
341,972
-16.7%
0.11%
-9.8%
 Xilio Therapeutics Inc$1,090
-99.9%
416,0590.0%0.11%
-23.0%
 Nauticus Robotics Inc.$1,060
-99.9%
500,0000.0%0.10%
-33.3%
PRAX SellPraxis Precision Medicines Inc$797
-99.9%
692,617
-11.0%
0.08%
+18.2%
 Pardes Biosciences Inc$724
-99.9%
400,0000.0%0.07%
+29.1%
MCRB  Seres Therapeutics Inc$632
-99.9%
131,8470.0%0.06%
-21.5%
 Surrozen Inc$455
-99.9%
826,8520.0%0.04%
-13.5%
SellDisc Medicine Inc$375
-99.9%
8,452
-66.2%
0.04%
-33.9%
MGTA  Magenta Therapeutics Inc$252
-99.9%
332,6100.0%0.02%
-10.7%
LOCO ExitEl Pollo Loco Holdings Inc$0-45,188
-100.0%
-0.05%
PATH ExitUI Path Inccl a$0-69,073
-100.0%
-0.13%
DYN ExitDyne Therapeutics Inc$0-107,252
-100.0%
-0.13%
AFRM ExitAffirm Hldgs Inc$0-173,560
-100.0%
-0.21%
MU ExitMicron Technology Inc$0-107,522
-100.0%
-0.68%
INTC ExitIntel Corp$0-207,752
-100.0%
-0.71%
RVMD ExitRevolution Medicines Inc$0-315,550
-100.0%
-0.72%
PLRX ExitPliant Therapeutics Inc$0-281,189
-100.0%
-0.79%
RLAY ExitRelay Therapeutics Inc$0-541,124
-100.0%
-0.94%
LRCX ExitLam Research Corp$0-19,131
-100.0%
-1.07%
ExitMeli Kaszek Pioneer Corpclass a ord$0-1,000,000
-100.0%
-1.07%
QRVO ExitQorvo Inc$0-104,669
-100.0%
-1.12%
ADI ExitAnalog Devices Inc$0-54,568
-100.0%
-1.13%
AMAT ExitApplied Matls Inc$0-88,443
-100.0%
-1.14%
ABCL ExitAbcellera Biologics Inc$0-4,105,095
-100.0%
-3.25%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

Compare quarters

Export HARVARD MANAGEMENT CO INC's holdings